Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy

NCT04169321 is registered in ClinicalTrials.gov with Cytosite Biopharma Inc. as lead sponsor.

NCT NCT04169321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04169321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy
Lead sponsor
Cytosite Biopharma Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 16, 2020
Completion date
June 9, 2025
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, solid tumor, unspecified, adult